Case Study: How a Custom Partnership Helped One Diagnostics Company Grow Globally During the COVID-19 Pandemic

March, 2022


This paper summarizes LumiraDx’s move to meet global demands for SARS-CoV-2 testing in response to the COVID-19 pandemic, assisted by our Custom Manufacturing team.


A point-of-care diagnostic company wants to expand their SARS-CoV-2 testing capabilities but needs to efficiently produce reliable enzymes and quickly reach global markets.


Combining LumiraDx’s diagnostic platform with an established pipeline for custom enzyme production resulted in a high-throughput, accurate COVID-19 testing solution for worldwide laboratories to use during a time of extreme uncertainty.

Download Case Study

Custom Manufacturing/OEM

Learn More

We're happy to answer any questions you may have and work with you to support your needs.

Request a Consult